Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Dettling

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Psychiatrische Praxis|December 9, 2004
[Neurocognition, psychosocial outcome and vocational integration]Timo Krüger, Manfred Schönhoff, Michael Dettling
The New England Journal of Medicine|February 8, 2008
Electroconvulsive therapy for depressionMichael Dettling, Ion Anghelescu, Malek Bajbouj
JAMA|October 16, 2008
Escitalopram, problem-solving therapy, and poststroke depressionMichael Dettling, Carolin Opgen-Rhein, Ion Anghelescu
The New England Journal of Medicine|October 3, 2006
Homocysteine lowering and cognitive performanceMichael Dettling, Carolin Opgen-Rhein, Ion-George Anghelescu
Journal of Clinical Psychopharmacology|January 17, 2007
Transient hyperglycemia and decreased glucose tolerance during antipsychotic monotherapy with amisulprideCarolin Opgen-Rhein, Andres H Neuhaus, Michael Dettling
Journal of Clinical Psychopharmacology|July 3, 2004
Mutation analysis of the ryanodine receptor gene isoform 3 (RYR3) in recurrent neuroleptic malignant syndromeMichael Dettling, Thomas Sander, Markus Weber, et al.
Psychiatrische Praxis|December 9, 2004
[New strategies in schizophrenia: impact of endophentotypes]Carolin Opgen-Rhein, Andres Neuhaus, Carsten Urbanek, et al.
The Journal of Clinical Psychiatry|August 10, 2007
Eosinophilia indicating subclinical clozapine-induced pericarditisKatrin Körtner, Andres H Neuhaus, Falk Schürer, et al.
JAMA|November 23, 2006
Fluoxetine for treatment of anorexia nervosaMichael Dettling, Carolin Opgen-Rhein, Arnim Quante, et al.
Journal of Clinical Psychopharmacology|September 15, 2005
Drug-induced agranulocytosis: impact of different fcgamma receptor polymorphisms?Igor Mosyagin, Ingolf Cascorbi, Rainer Schaub, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Psychiatrische Praxis|December 9, 2004
[Neurocognition, psychosocial outcome and vocational integration]Timo Krüger, Manfred Schönhoff, Michael Dettling
The New England Journal of Medicine|February 8, 2008
Electroconvulsive therapy for depressionMichael Dettling, Ion Anghelescu, Malek Bajbouj
JAMA|October 16, 2008
Escitalopram, problem-solving therapy, and poststroke depressionMichael Dettling, Carolin Opgen-Rhein, Ion Anghelescu
The New England Journal of Medicine|October 3, 2006
Homocysteine lowering and cognitive performanceMichael Dettling, Carolin Opgen-Rhein, Ion-George Anghelescu
Journal of Clinical Psychopharmacology|January 17, 2007
Transient hyperglycemia and decreased glucose tolerance during antipsychotic monotherapy with amisulprideCarolin Opgen-Rhein, Andres H Neuhaus, Michael Dettling
Journal of Clinical Psychopharmacology|July 3, 2004
Mutation analysis of the ryanodine receptor gene isoform 3 (RYR3) in recurrent neuroleptic malignant syndromeMichael Dettling, Thomas Sander, Markus Weber, et al.
Psychiatrische Praxis|December 9, 2004
[New strategies in schizophrenia: impact of endophentotypes]Carolin Opgen-Rhein, Andres Neuhaus, Carsten Urbanek, et al.
The Journal of Clinical Psychiatry|August 10, 2007
Eosinophilia indicating subclinical clozapine-induced pericarditisKatrin Körtner, Andres H Neuhaus, Falk Schürer, et al.
JAMA|November 23, 2006
Fluoxetine for treatment of anorexia nervosaMichael Dettling, Carolin Opgen-Rhein, Arnim Quante, et al.
Journal of Clinical Psychopharmacology|September 15, 2005
Drug-induced agranulocytosis: impact of different fcgamma receptor polymorphisms?Igor Mosyagin, Ingolf Cascorbi, Rainer Schaub, et al.
Pageof 7